Form 4: Director Melenikiotou Acquires Shares of Inspire Medical Systems in Lieu of Cash Fees
SEC Form 4 Filing
Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 102 shares of common stock on April 14, 2025, in lieu of cash fees.
Summary
- On April 14, 2025, Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 102 shares of common stock.
- The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
- The price per share was $149.7.
- Following the transaction, Melenikiotou directly owns 2,395 shares of Inspire Medical Systems.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to director compensation.
Positives
- A director's decision to take shares in lieu of cash may signal confidence in the company's future performance.
Industry Context
Director stock ownership changes are routinely monitored by investors as signals of management's confidence in the company's prospects. This transaction is part of the standard compensation practices for non-employee directors.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals director confidence.
Key Dates
| Date | Description |
|---|---|
| 04/14/2025 | Date of transaction: Georgia Melenikiotou acquired 102 shares of common stock. |
| 04/16/2025 | Date of signature on the Form 4 filing. |
Keywords
Inspire Medical Systems, INSP, Georgia Melenikiotou, Director, Stock Acquisition, Form 4, Non-Employee Director Compensation Policy, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.